Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
title:"systemat review"
journalStr:"Health technology assessment (Winchester, England)"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=title%3A%22systemat+review%22&filter%5B%5D=journalStr%3A%22Health+technology+assessment+%28Winchester%2C+England%29%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
/vufind/Search/Results?filter%5B%5D=title%3A%22systemat+review%22&filter%5B%5D=journalStr%3A%22Health+technology+assessment+%28Winchester%2C+England%29%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=title%3A%22systemat+review%22&filter%5B%5D=journalStr%3A%22Health+technology+assessment+%28Winchester%2C+England%29%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
PubPharm (24)
1
A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults
enthalten in:
Health technology assessment (Winchester, England)
| 2017
von
Squires, H.
|
Poku, E.
|
Bermejo, I.
| +7
Wird geladen...
2
Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs : a systematic review and economic evaluation
enthalten in:
Health technology assessment (Winchester, England)
| 2017
von
Corbett, M.
|
Chehadah, F.
|
Biswas, M.
| +8
Wird geladen...
3
The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis : a systematic review and economic evaluation
enthalten in:
Health technology assessment (Winchester, England)
| 2016
von
Shepherd, J.
|
Cooper, K.
|
Harris, P.
| +2
Wird geladen...
4
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only : systematic review and economic evaluation
enthalten in:
Health technology assessment (Winchester, England)
| 2016
von
Stevenson, M.
|
Archer, R.
|
Tosh, J.
| +9
ErratumIn: Health Technol Assess. 2016 Nov;20(35):611-614. - PMID 27919316
Wird geladen...
5
Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis : a systematic review and economic evaluation
enthalten in:
Health technology assessment (Winchester, England)
| 2016
von
Corbett, M.
|
Soares, M.
|
Jhuti, G.
| +9
Wird geladen...
6
KRAS mutation testing of tumours in adults with metastatic colorectal cancer : a systematic review and cost-effectiveness analysis
enthalten in:
Health technology assessment (Winchester, England)
| 2014
von
Westwood, M.
|
van Asselt, T.
|
Ramaekers, B.
| +7
Wird geladen...
7
Omalizumab for the treatment of severe persistent allergic asthma : a systematic review and economic evaluation
enthalten in:
Health technology assessment (Winchester, England)
| 2013
von
Norman, G.
|
Faria, R.
|
Paton, F.
| +7
Wird geladen...
8
Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours
enthalten in:
Health technology assessment (Winchester, England)
| 2013
von
Ford, J.
|
Cummins, E.
|
Sharma, P.
| +8
Wird geladen...
9
The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118) : a systematic review and economic model
enthalten in:
Health technology assessment (Winchester, England)
| 2013
von
Hoyle, M.
|
Crathorne, L.
|
Peters, J.
| +5
Wird geladen...
10
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor : a systematic review and economic evaluation
enthalten in:
Health technology assessment (Winchester, England)
| 2011
von
Malottki, K.
|
Barton, P.
|
Tsourapas, A.
| +8
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Filter aufheben
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Health technology assessment (Winchester, England)
Medienart
24
Aufsätze
21
E-Artikel
21
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
Health technology assessment (Winchester, England)
Thema
24
Antibodies, Monoclonal, Humanized
24
Journal Article
24
Review
24
Systematic Review
18
Antibodies, Monoclonal
9
Research Support, Non-U.S. Gov't
8
Adalimumab
8
Antirheumatic Agents
8
FYS6T7F842
7
Etanercept
7
OP401G7OJC
6
B72HH48FLU
6
Immunoglobulin G
6
Infliximab
5
Receptors, Tumor Necrosis Factor
4
2S9ZZM9Q9V
4
Antineoplastic Agents
4
Bevacizumab
4
Meta-Analysis
4
Tumor Necrosis Factor-alpha
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
15
2010-2019
9
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
24
Englisch
Haven't found what you're looking for?
Wird geladen...